Cornerstone Planning Group’s ClearPoint Neuro CLPT Stock Holding History

Cornerstone Planning Group’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$375	Buy	+38	New	+$360	﹤0.01%	1476

Other funds holding CLPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWM

Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Cornerstone Planning Group's CLPT Position: Q4 2022 in Review

Cornerstone Planning Group opened a new position in ClearPoint Neuro (CLPT) in Q4 2022: 38 shares worth $375. The stake represents ﹤0.01% of the portfolio and ranks #1476 among its holdings.

62 funds tracked by Wall St. Rank hold CLPT as of Q4 2022.

Cornerstone Planning Group held 38 shares of ClearPoint Neuro worth $375 as of Q4 2022.
ClearPoint Neuro was a new Cornerstone Planning Group position in Q4 2022.
ClearPoint Neuro made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q4 2022, its #1476 holding.
62 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q4 2022.

Based on Cornerstone Planning Group's 13F filing for Q4 2022, filed 14 Feb 2023.